BMP antagonists, such as gremlin and noggin, are potentially important mediators of vascular changes in hypoxic pulmonary hypertension, have been implicated plays an key role in the pathophysiology of pulmonary arterial hypertension [32, 36]. Here, NOG is linked to pulmonary arterial hypertension.